Groupama Asset Managment Boosts Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Groupama Asset Managment lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 27.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 66,706 shares of the medical equipment provider’s stock after acquiring an additional 14,510 shares during the period. Groupama Asset Managment’s holdings in Intuitive Surgical were worth $35,151,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Trexquant Investment LP acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $9,301,000. Geode Capital Management LLC raised its position in shares of Intuitive Surgical by 3.2% in the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock worth $4,039,200,000 after buying an additional 243,802 shares during the period. National Wealth Management Group LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth $436,000. Nemes Rush Group LLC boosted its holdings in Intuitive Surgical by 7.2% in the fourth quarter. Nemes Rush Group LLC now owns 344 shares of the medical equipment provider’s stock valued at $180,000 after acquiring an additional 23 shares during the last quarter. Finally, HighPoint Advisor Group LLC grew its position in Intuitive Surgical by 6.8% during the fourth quarter. HighPoint Advisor Group LLC now owns 5,160 shares of the medical equipment provider’s stock valued at $2,693,000 after acquiring an additional 327 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other news, VP Fredrik Widman sold 810 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the transaction, the vice president now owns 473 shares of the company’s stock, valued at approximately $271,397.94. This trade represents a 63.13 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 269 shares of the business’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the sale, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at approximately $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 in the last ninety days. 0.70% of the stock is owned by insiders.

Intuitive Surgical Trading Up 0.7 %

ISRG stock opened at $495.27 on Tuesday. The firm has a 50 day simple moving average of $554.33 and a 200-day simple moving average of $532.98. The company has a market capitalization of $176.40 billion, a P/E ratio of 77.27, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Truist Financial cut their price objective on Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a report on Monday, March 17th. Leerink Partners raised their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Royal Bank of Canada boosted their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Finally, Raymond James lifted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.